Ingersoll Rand Reports First Quarter 2025 Results
Delivered Record First Quarter Orders, Revenue, and Free Cash Flow
First Quarter 2025 Highlights
(All comparisons against the first quarter of 2024 unless otherwise noted.)
Strong performance driven by its competitive differentiator -
-
Reported orders of
$1,882 million , up 10% -
Reported revenues of
$1,717 million , up 3% -
Reported net income attributable to
Ingersoll Rand Inc. of$187 million , or earnings of$0.46 per share-
Adjusted net income1 of
$293 million , or$0.72 per share
-
Adjusted net income1 of
-
Adjusted EBITDA1 of
$460 million , flat, with a margin of 26.8%, down 70 basis points year over year -
Reported operating cash flow of
$256 million and free cash flow1 of$223 million , up 59% and 124%, respectively -
Liquidity of
$4.2 billion as ofMarch 31, 2025 , including$1.6 billion of cash on hand and undrawn capacity of$2.6 billion under available credit facilities -
The Board has authorized a
$1 billion increase to the Company’s share repurchase program. -
The Company remains confident in its long-term value creation and strong cash generation
-
Continue to focus on bolt-on acquisitions as well as targeting up to
$750 million of share repurchases by the end of 2025
-
Continue to focus on bolt-on acquisitions as well as targeting up to
“Our positive organic orders growth, solid book-to-bill, and record first quarter free cash flow are encouraging signs as we start off the year,” said
First Quarter 2025 Segment Review
(All comparisons against the first quarter of 2024 unless otherwise noted.)
Industrial Technologies and Services Segment (IT&S): Broad range of compressor, vacuum, blower, and air treatment solutions as well as industrial technologies including power tools and lifting equipment
-
Reported Orders
of
$1,487 million , up 6%, or up 3% organic -
Reported Revenues
of
$1,352 million , down 2%, or down 4% organic1 -
Reported Segment Adjusted EBITDA
of
$389 million , down 5% - Reported Segment Adjusted EBITDA Margin of 28.8%, down 110 basis points
- IT&S saw strong first quarter organic orders growth, with a book to bill of 1.10x, finishing largely in line with expectations. Adjusted EBITDA margin was down year over year, driven largely by the flow through on organic volume declines, the expected dilutive impact from recently acquired acquisitions, and continued commercial investments for growth.
Precision and Science Technologies Segment (P&ST): Mission-critical precision liquid, gas, air, and powder handling technologies for life sciences and industrial applications as well as aerospace and defense applications
-
Reported Orders
of
$395 million , up 28%, or up 3% organic -
Reported Revenues
of
$365 million , up 23%, or down 3% organic1 -
Reported Segment Adjusted EBITDA
of
$106 million , up 16% - Reported Segment Adjusted EBITDA Margin of 29.1%, down 170 basis points
-
With a book to bill of 1.08x, P&ST delivered low single-digit organic orders growth in both the
Precision Technologies andLife Science Technologies businesses. Adjusted EBITDA margin finished largely in line with expectations and improved 150 basis points sequentially from the fourth quarter of 2024.
Balance Sheet and Cash Flow
The Board also authorized a
These authorizations do not have any expiration date and allow
Consistent with our comprehensive capital allocation strategy led by M&A, in the first quarter of 2025,
-
G & D Chillers, Inc. , a leadingU.S. manufacturer of premium glycol chillers used to cool liquids primarily in the food and beverage end market -
Advanced Gas Technologies Inc. , a custom designer and supplier of onsite gas generation systems serving industrial customers primarily inCanada
The Company also returned approximately
_______________________________ |
1 Non-GAAP measure (definitions and/or reconciliations in tables below) |
2 Calculated as Net Debt to LTM Adjusted EBITDA |
2025 Guidance
|
Key Metrics |
||
|
Initial Guidance
|
Revised Guidance
|
|
Revenue - Total Ingersoll Rand2 |
3-5% |
3-5% |
|
|
1-3% |
(1)-1% |
|
Industrial Technologies & Services (Organic)1 |
1-3% |
(1)-1% |
|
Precision & Science Technologies (Organic)1 |
1-3% |
(1)-1% |
|
FX Impact3 |
(~2%) |
(~0.5%) |
|
M&A4 |
|
|
|
Corporate Costs |
( |
( |
|
Adjusted EBITDA1 |
|
|
|
Adjusted EPS1 |
|
|
Reconciliations of non-GAAP measures related to full-year 2025 guidance have not been provided due to the unreasonable efforts it would take to provide such reconciliations due to the high variability, complexity and uncertainty with respect to forecasting and quantifying certain amounts that are necessary for such reconciliations, including net income (loss) and adjustments that could be made for acquisitions-related expenses, restructuring and other business transformation costs, gains or losses on foreign currency exchange and the timing and magnitude of other amounts in the reconciliation of historic numbers. For the same reasons, we are unable to address the probable significance of the unavailable information, which could have a potentially unpredictable, and potentially significant, impact on our future GAAP financial results.
__________________________________________
1 Non-GAAP measure (definitions and/or reconciliations in tables below) |
2 All revenue outlook commentary expressed in percentages and based on growth as compared to 2024 |
3 Based on |
4 Reflects all completed and closed M&A as of |
Conference Call
Forward-Looking Statements
This news release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, including statements related to the expectations of
These forward-looking statements are based on Ingersoll Rand’s current expectations and are subject to risks and uncertainties, which may cause actual results to differ materially from these current expectations. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those indicated or anticipated by such forward-looking statements. The inclusion of such statements should not be regarded as a representation that such plans, estimates or expectations will be achieved. Important factors that could cause actual results to differ materially from such plans, estimates or expectations include, among others, (1) adverse impact on our operations and financial performance due to natural disaster, catastrophe, global pandemics, geopolitical tensions, cyber events, or other events outside of our control; (2) unexpected costs, charges or expenses resulting from completed and proposed business combinations; (3) uncertainty of the expected financial performance of the Company; (4) failure to realize the anticipated benefits of completed and proposed business combinations; (5) the ability of the Company to implement its business strategy; (6) difficulties and delays in achieving revenue and cost synergies; (7) inability of the Company to retain and hire key personnel; (8) evolving legal, regulatory and tax regimes; (9) changes in general economic and/or industry specific conditions; (10) actions by third parties, including government agencies; and (11) other risk factors detailed in Ingersoll Rand’s most recent Annual Report on Form 10-K filed with the
Any forward-looking statements speak only as of the date of this release.
About
# # #
Non-
In addition to consolidated GAAP financial measures,
Management and Ingersoll Rand’s board of directors regularly use these measures as tools in evaluating the Company’s operating and financial performance and in establishing discretionary annual compensation. Such measures are provided in addition to and should not be considered to be a substitute for, or superior to, the comparable measures under GAAP. In addition,
Organic Revenue Growth/(Decline), Adjusted EBITDA, Adjusted EBITDA Margin, Adjusted Net Income, Adjusted Diluted EPS, Free Cash Flow and Free Cash Flow Margin should not be considered as alternatives to revenue growth, net income, diluted earnings per share or any other performance measure derived in accordance with GAAP, or as alternatives to cash flow from operating activities as a measure of our liquidity. Organic Revenue Growth/(Decline), Adjusted EBITDA, Adjusted EBITDA Margin, Adjusted Net Income, Adjusted Diluted EPS, Free Cash Flow and Free Cash Flow Margin have limitations as analytical tools, and you should not consider such measures either in isolation or as substitutes for analyzing Ingersoll Rand’s results as reported under GAAP.
Reconciliations of Organic Revenue Growth/(Decline), Adjusted EBITDA, Adjusted EBITDA Margin, Adjusted Net Income, Adjusted Diluted EPS, Free Cash Flow and Free Cash Flow Margin to their most comparable
Reconciliations of non-GAAP measures related to full-year 2025 guidance have not been provided due to the unreasonable efforts it would take to provide such reconciliations due to the high variability, complexity and uncertainty with respect to forecasting and quantifying certain amounts that are necessary for such reconciliations, including net income (loss) and adjustments that could be made for acquisitions-related expenses, restructuring and other business transformation costs, gains or losses on foreign currency exchange and the timing and magnitude of other amounts in the reconciliation of historic numbers. For the same reasons, we are unable to address the probable significance of the unavailable information, which could have a potentially unpredictable, and potentially significant, impact on our future GAAP financial results.
Due to rounding, numbers presented throughout this release may not sum precisely to the totals provided and percentages may not precisely reflect the absolute figures.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited; in millions, except per share amounts) |
|||||||
|
For the Three Month Period
|
||||||
|
|
2025 |
|
|
|
2024 |
|
Revenues |
$ |
1,716.8 |
|
|
$ |
1,670.1 |
|
Cost of sales |
|
951.3 |
|
|
|
923.8 |
|
Gross Profit |
|
765.5 |
|
|
|
746.3 |
|
Selling and administrative expenses |
|
350.0 |
|
|
|
336.3 |
|
Amortization of intangible assets |
|
91.3 |
|
|
|
91.6 |
|
Other operating expense, net |
|
21.7 |
|
|
|
25.2 |
|
Operating Income |
|
302.5 |
|
|
|
293.2 |
|
Interest expense |
|
61.2 |
|
|
|
36.8 |
|
Other income, net |
|
(11.8 |
) |
|
|
(13.2 |
) |
Income Before Income Taxes |
|
253.1 |
|
|
|
269.6 |
|
Provision for income taxes |
|
58.5 |
|
|
|
54.4 |
|
Loss on equity method investments |
|
(6.2 |
) |
|
|
(10.7 |
) |
Net Income |
|
188.4 |
|
|
|
204.5 |
|
Less: Net income attributable to noncontrolling interests |
|
1.9 |
|
|
|
2.3 |
|
Net Income Attributable to |
$ |
186.5 |
|
|
$ |
202.2 |
|
|
|
|
|
||||
Basic earnings per share |
|
0.46 |
|
|
|
0.50 |
|
Diluted earnings per share |
|
0.46 |
|
|
|
0.50 |
|
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited; in millions, except share amounts) |
|||||||
|
|
|
|
||||
Assets |
|
|
|
||||
Current assets: |
|
|
|
||||
Cash and cash equivalents |
$ |
1,612.8 |
|
|
$ |
1,541.2 |
|
Accounts receivable, net of allowance for credit losses of |
|
1,348.3 |
|
|
|
1,335.4 |
|
Inventories |
|
1,133.0 |
|
|
|
1,055.0 |
|
Other current assets |
|
257.6 |
|
|
|
231.9 |
|
Total current assets |
|
4,351.7 |
|
|
|
4,163.5 |
|
Property, plant and equipment, net of accumulated depreciation of |
|
852.9 |
|
|
|
842.1 |
|
|
|
8,339.1 |
|
|
|
8,148.1 |
|
Other intangible assets, net |
|
4,360.5 |
|
|
|
4,372.8 |
|
Deferred tax assets |
|
26.3 |
|
|
|
26.1 |
|
Other assets |
|
448.9 |
|
|
|
457.2 |
|
Total assets |
$ |
18,379.4 |
|
|
$ |
18,009.8 |
|
Liabilities and Stockholders' Equity |
|
|
|
||||
Current liabilities: |
|
|
|
||||
Short-term borrowings and current maturities of long-term debt |
$ |
1.7 |
|
|
$ |
3.1 |
|
Accounts payable |
|
780.4 |
|
|
|
843.6 |
|
Accrued liabilities |
|
1,044.7 |
|
|
|
972.2 |
|
Total current liabilities |
|
1,826.8 |
|
|
|
1,818.9 |
|
Long-term debt, less current maturities |
|
4,770.4 |
|
|
|
4,754.4 |
|
Pensions and other postretirement benefits |
|
142.5 |
|
|
|
139.3 |
|
Deferred income tax liabilities |
|
756.6 |
|
|
|
757.6 |
|
Other liabilities |
|
329.4 |
|
|
|
294.3 |
|
Total liabilities |
$ |
7,825.7 |
|
|
$ |
7,764.5 |
|
Stockholders’ equity: |
|
|
|
||||
Common stock, |
|
4.3 |
|
|
|
4.3 |
|
Capital in excess of par value |
|
9,651.7 |
|
|
|
9,633.6 |
|
Retained earnings |
|
2,681.9 |
|
|
|
2,503.5 |
|
Accumulated other comprehensive loss |
|
(350.5 |
) |
|
|
(468.5 |
) |
|
|
(1,502.6 |
) |
|
|
(1,493.9 |
) |
Total |
$ |
10,484.8 |
|
|
$ |
10,179.0 |
|
Noncontrolling interests |
|
68.9 |
|
|
|
66.3 |
|
Total stockholders’ equity |
$ |
10,553.7 |
|
|
$ |
10,245.3 |
|
Total liabilities and stockholders’ equity |
$ |
18,379.4 |
|
|
$ |
18,009.8 |
|
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited; in millions) |
|||||||
|
Three Month Period
|
||||||
|
|
2025 |
|
|
|
2024 |
|
Cash Flows From Operating Activities: |
|
|
|||||
Net income |
$ |
188.4 |
|
|
$ |
204.5 |
|
Adjustments to reconcile net income to net cash provided by operating activities: |
|
|
|
||||
Amortization of intangible assets |
|
91.3 |
|
|
|
91.6 |
|
Depreciation |
|
28.7 |
|
|
|
25.6 |
|
Stock-based compensation expense |
|
14.2 |
|
|
|
14.1 |
|
Loss on equity method investments |
|
6.2 |
|
|
|
10.7 |
|
Foreign currency transaction losses (gains), net |
|
6.8 |
|
|
|
(0.7 |
) |
Non-cash adjustments to carrying value of LIFO inventories |
|
3.0 |
|
|
|
6.7 |
|
Other non-cash adjustments |
|
2.4 |
|
|
|
1.4 |
|
Changes in assets and liabilities: |
|
|
|
||||
Receivables |
|
25.3 |
|
|
|
(11.5 |
) |
Inventories |
|
(54.1 |
) |
|
|
(58.2 |
) |
Accounts payable |
|
(70.4 |
) |
|
|
(101.5 |
) |
Accrued liabilities |
|
39.7 |
|
|
|
(1.8 |
) |
Other assets and liabilities, net |
|
(25.1 |
) |
|
|
(19.3 |
) |
Net cash provided by operating activities |
|
256.4 |
|
|
|
161.6 |
|
Cash Flows Used In Investing Activities: |
|
|
|
||||
Capital expenditures |
|
(33.7 |
) |
|
|
(62.3 |
) |
Net cash paid in acquisitions |
|
(163.4 |
) |
|
|
(143.3 |
) |
Net cash used in investing activities |
|
(197.1 |
) |
|
|
(205.6 |
) |
Cash Flows Used In Financing Activities: |
|
|
|
||||
Principal payments on long-term debt |
|
— |
|
|
|
(7.1 |
) |
Purchases of treasury stock |
|
(10.0 |
) |
|
|
(72.9 |
) |
Cash dividends on common shares |
|
(8.1 |
) |
|
|
(8.1 |
) |
Proceeds from stock option exercises |
|
5.2 |
|
|
|
11.2 |
|
Payments of deferred and contingent acquisition consideration |
|
(1.4 |
) |
|
|
(2.2 |
) |
Other financing |
|
4.3 |
|
|
|
(0.5 |
) |
Net cash used in financing activities |
|
(10.0 |
) |
|
|
(79.6 |
) |
Effect of exchange rate changes on cash and cash equivalents |
|
22.3 |
|
|
|
(19.6 |
) |
Net increase (decrease) in cash and cash equivalents |
|
71.6 |
|
|
|
(143.2 |
) |
Cash and cash equivalents, beginning of period |
|
1,541.2 |
|
|
|
1,595.5 |
|
Cash and cash equivalents, end of period |
$ |
1,612.8 |
|
|
$ |
1,452.3 |
|
UNAUDITED ADJUSTED FINANCIAL INFORMATION (Dollars in millions) |
|||||||
|
For the Three Month Period
|
||||||
|
|
2025 |
|
|
|
2024 |
|
Revenues |
$ |
1,716.8 |
|
|
$ |
1,670.1 |
|
Adjusted EBITDA |
$ |
459.7 |
|
|
$ |
458.5 |
|
Adjusted EBITDA Margin |
|
26.8 |
% |
|
|
27.5 |
% |
Free Cash Flow |
$ |
222.7 |
|
|
$ |
99.3 |
|
Free Cash Flow Margin |
|
13.0 |
% |
|
|
5.9 |
% |
RECONCILIATION OF NET INCOME TO ADJUSTED NET INCOME AND ADJUSTED NET INCOME ATTRIBUTABLE TO INGERSOLL RAND INC. AND ADJUSTED DILUTED EARNINGS PER SHARE (Unaudited; in millions) |
|||||||
|
For the Three Month Period
|
||||||
|
|
2025 |
|
|
|
2024 |
|
Net Income |
$ |
188.4 |
|
|
$ |
204.5 |
|
Plus: |
|
|
|
||||
Provision for income taxes |
|
58.5 |
|
|
|
54.4 |
|
Amortization of acquisition related intangible assets |
|
89.0 |
|
|
|
89.5 |
|
Restructuring and related business transformation costs |
|
5.4 |
|
|
|
10.7 |
|
Acquisition and other transaction related expenses and non-cash charges |
|
9.8 |
|
|
|
15.3 |
|
Stock-based compensation |
|
14.2 |
|
|
|
14.1 |
|
Foreign currency transaction losses (gains), net |
|
6.8 |
|
|
|
(0.7 |
) |
Loss on equity method investments |
|
6.2 |
|
|
|
10.7 |
|
Adjustments to LIFO inventories |
|
3.0 |
|
|
|
6.8 |
|
Cybersecurity incident costs |
|
(0.2 |
) |
|
|
0.6 |
|
Other adjustments |
|
(2.2 |
) |
|
|
0.4 |
|
Minus: |
|
|
|
||||
Income tax provision, as adjusted |
|
85.7 |
|
|
|
86.4 |
|
Adjusted Net Income |
|
293.2 |
|
|
|
319.9 |
|
Less: Net income attributable to noncontrolling interest |
|
1.9 |
|
|
|
2.3 |
|
Adjusted Net Income Attributable to |
$ |
291.3 |
|
|
$ |
317.6 |
|
|
|
|
|
||||
Adjusted Basic Earnings Per Share1 |
$ |
0.72 |
|
|
$ |
0.79 |
|
Adjusted Diluted Earnings Per Share2 |
$ |
0.72 |
|
|
$ |
0.78 |
|
|
|
|
|
||||
Average shares outstanding: |
|
|
|
||||
Basic, as reported |
|
403.1 |
|
|
|
403.5 |
|
Diluted, as reported |
|
406.4 |
|
|
|
407.9 |
|
Adjusted diluted2 |
|
406.4 |
|
|
|
407.9 |
|
1 Basic and diluted earnings per share (as reported) are calculated by dividing net income attributable to |
2 Adjusted diluted share count and adjusted diluted earnings per share include incremental dilutive shares, using the treasury stock method, which are added to average shares outstanding. |
RECONCILIATION OF NET INCOME TO ADJUSTED EBITDA AND ADJUSTED NET INCOME AND CASH FLOWS FROM OPERATING ACTIVITIES TO FREE CASH FLOW (Unaudited; in millions) |
|||||||
|
For the Three Month Period
|
||||||
|
|
2025 |
|
|
|
2024 |
|
Net Income |
$ |
188.4 |
|
|
$ |
204.5 |
|
Plus: |
|
|
|
||||
Interest expense |
|
61.2 |
|
|
|
36.8 |
|
Provision for income taxes |
|
58.5 |
|
|
|
54.4 |
|
Depreciation expense |
|
27.6 |
|
|
|
24.7 |
|
Amortization expense |
|
91.3 |
|
|
|
91.6 |
|
Restructuring and related business transformation costs |
|
5.4 |
|
|
|
10.7 |
|
Acquisition and other transaction related expenses and non-cash charges |
|
9.8 |
|
|
|
15.3 |
|
Stock-based compensation |
|
14.2 |
|
|
|
14.1 |
|
Foreign currency transaction losses (gains), net |
|
6.8 |
|
|
|
(0.7 |
) |
Loss on equity method investments |
|
6.2 |
|
|
|
10.7 |
|
Adjustments to LIFO inventories |
|
3.0 |
|
|
|
6.8 |
|
Cybersecurity incident costs |
|
(0.2 |
) |
|
|
0.6 |
|
Interest income on cash and cash equivalents |
|
(10.3 |
) |
|
|
(11.4 |
) |
Other adjustments |
|
(2.2 |
) |
|
|
0.4 |
|
Adjusted EBITDA |
$ |
459.7 |
|
|
$ |
458.5 |
|
Minus: |
|
|
|
||||
Interest expense |
|
61.2 |
|
|
|
36.8 |
|
Income tax provision, as adjusted |
|
85.7 |
|
|
|
86.4 |
|
Depreciation expense |
|
27.6 |
|
|
|
24.7 |
|
Amortization of non-acquisition related intangible assets |
|
2.3 |
|
|
|
2.1 |
|
Interest income on cash and cash equivalents |
|
(10.3 |
) |
|
|
(11.4 |
) |
Adjusted Net Income |
$ |
293.2 |
|
|
$ |
319.9 |
|
|
|
|
|
||||
Free Cash Flow: |
|
|
|
||||
Cash flows from operating activities |
$ |
256.4 |
|
|
$ |
161.6 |
|
Minus: |
|
|
|
||||
Capital expenditures |
|
33.7 |
|
|
|
62.3 |
|
Free Cash Flow |
$ |
222.7 |
|
|
$ |
99.3 |
|
RECONCILIATION OF SEGMENT ADJUSTED EBITDA TO NET INCOME (Unaudited; in millions) |
|||||||
|
For the Three Month Period
|
||||||
|
|
2025 |
|
|
|
2024 |
|
Orders |
|
|
|
||||
Industrial Technologies and Services |
$ |
1,487.0 |
|
|
$ |
1,398.4 |
|
Precision and Science Technologies |
|
395.3 |
|
|
|
309.0 |
|
Total Orders |
$ |
1,882.3 |
|
|
$ |
1,707.4 |
|
Revenue |
|
|
|
||||
Industrial Technologies and Services |
$ |
1,352.1 |
|
|
$ |
1,373.4 |
|
Precision and Science Technologies |
|
364.7 |
|
|
|
296.7 |
|
Total Revenue |
$ |
1,716.8 |
|
|
$ |
1,670.1 |
|
Segment Adjusted EBITDA |
|
|
|
||||
Industrial Technologies and Services |
$ |
389.1 |
|
|
$ |
411.1 |
|
Precision and Science Technologies |
|
106.2 |
|
|
|
91.4 |
|
Total Segment Adjusted EBITDA |
$ |
495.3 |
|
|
$ |
502.5 |
|
Less items to reconcile Segment Adjusted EBITDA to Income Before Income Taxes: |
|
|
|
||||
Corporate expenses not allocated to segments |
$ |
35.6 |
|
|
$ |
44.0 |
|
Interest expense |
|
61.2 |
|
|
|
36.8 |
|
Depreciation and amortization expense |
|
118.9 |
|
|
|
116.3 |
|
Restructuring and related business transformation costs |
|
5.4 |
|
|
|
10.7 |
|
Acquisition and other transaction related expenses and non-cash charges |
|
9.8 |
|
|
|
15.3 |
|
Stock-based compensation |
|
14.2 |
|
|
|
14.1 |
|
Foreign currency transaction losses (gains), net |
|
6.8 |
|
|
|
(0.7 |
) |
Adjustments to LIFO inventories |
|
3.0 |
|
|
|
6.8 |
|
Cybersecurity incident costs |
|
(0.2 |
) |
|
|
0.6 |
|
Interest income on cash and cash equivalents |
|
(10.3 |
) |
|
|
(11.4 |
) |
Other adjustments |
|
(2.2 |
) |
|
|
0.4 |
|
Income Before Income Taxes |
|
253.1 |
|
|
|
269.6 |
|
Provision for income taxes |
|
58.5 |
|
|
|
54.4 |
|
Loss on equity method investments |
|
(6.2 |
) |
|
|
(10.7 |
) |
Net Income |
$ |
188.4 |
|
|
$ |
204.5 |
|
ORDERS AND REVENUE GROWTH (DECLINE) BY SEGMENT1 |
|||||
|
For the Three Month Period
|
||||
|
Orders |
|
Revenue |
||
|
|
|
|
||
Organic growth (decline) |
3.4 |
% |
|
(3.9 |
%) |
Impact of foreign currency |
(1.8 |
%) |
|
(1.7 |
%) |
Impact of acquisitions |
8.6 |
% |
|
8.4 |
% |
Total orders and revenue growth |
10.2 |
% |
|
2.8 |
% |
|
|
|
|
||
Industrial Technologies & Services |
|
|
|
||
Organic growth (decline) |
3.5 |
% |
|
(4.2 |
%) |
Impact of foreign currency |
(1.9 |
%) |
|
(1.7 |
%) |
Impact of acquisitions |
4.7 |
% |
|
4.3 |
% |
Total orders and revenue growth (decline) |
6.3 |
% |
|
(1.6 |
%) |
|
|
|
|
||
Precision & Science Technologies |
|
|
|
||
Organic growth (decline) |
2.9 |
% |
|
(2.7 |
%) |
Impact of foreign currency |
(1.4 |
%) |
|
(1.4 |
%) |
Impact of acquisitions |
26.4 |
% |
|
27.0 |
% |
Total orders and revenue growth |
27.9 |
% |
|
22.9 |
% |
1 Organic growth/(decline), impact of foreign currency, and impact of acquisitions are non-GAAP measures. References to “impact of acquisitions” refer to GAAP sales from acquired businesses recorded prior to the first anniversary of the acquisition. The portion of GAAP revenue attributable to currency translation is calculated as the difference between (a) the period-to-period change in revenue (excluding acquisition sales) and (b) the period-to-period change in revenue (excluding acquisition sales) after applying prior year foreign exchange rates to the current year period. |
View source version on businesswire.com: https://www.businesswire.com/news/home/20250501452731/en/
Investor Relations:
Matthew.Fort@irco.com
Media:
Sara.Hassell@irco.com
Source: